Evidence map›Paper›PMID 34710821›Full record

ArticleSocial science & medicine (1982)2021

The transgender-specific intimate partner violence scale for research and practice: Validation in a sample of transgender women.

Sarah M Peitzmeier, Andrea L Wirtz, Elizabeth Humes, Jaclyn M W Hughto, Erin Cooney, Sari L Reisner, American Cohort To Study HIV Acquisition Among Transgender Women (LITE)

Open access · greenAbstract read
In one paragraph

Article in Social science & medicine (1982), 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 32 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
32citing papers in PubMed, 2 pooled it
4.2field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

32 citing papers in PubMed, 2 syntheses or guidelines pooled it, 56 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Trial
  4. Trial
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 4 institutions in 1 country.

Sarah M PeitzmeierUniversity of Michigan School of Nursing, Center for Sexuality and Health Disparities, United States. Electronic address: speitzme@umich.edu.
Andrea L WirtzJohns Hopkins Bloomberg School of Public Health, Department of Epidemiology, United States.
Elizabeth HumesJohns Hopkins Bloomberg School of Public Health, Department of Epidemiology, United States.
Jaclyn M W HughtoBrown University, Departments of Behavioral and Social Sciences and Epidemiology, United States.
Erin CooneyJohns Hopkins Bloomberg School of Public Health, Department of Epidemiology, United States.
Sari L ReisnerBrigham and Women's Hospital, United States; Harvard TH Chan School of Public Health, United States; Department of Epidemiology, United States; The Fenway Institute, United States.
American Cohort To Study HIV Acquisition Among Transgender Women (LITE)
Johns Hopkins University · USBrigham and Women's Hospital · USJohn Brown University · USUniversity of Michigan · US

Funding

The impact of HIV viral diversity and cellular immunity on HIV pathogenesisP30AI060354 · NIAID · HARVARD UNIVERSITY (MEDICAL SCHOOL) · PI ROBERT A. PARKER · 2004 to 2026
$94.4M
Virology and Molecular Biomarkers CoreP30AI050409 · NIAID · EMORY UNIVERSITY · PI Carlos del Rio · 2002 to 2026
$74.0M
Vaccine Response and Immunotherapeutics SWGP30AI094189 · NIAID · JOHNS HOPKINS UNIVERSITY · PI Richard E. Chaisson · 2012 to 2026
$67.0M
University of Miami Developmental Center for AIDS Research (D-CFAR)P30AI073961 · NIAID · UNIVERSITY OF MIAMI SCHOOL OF MEDICINE · PI ALLAN E RODRIGUEZ · 2007 to 2026
$33.8M
SWG 2: Cure Research Scientific Working GroupP30AI117970 · NIAID · GEORGE WASHINGTON UNIVERSITY · PI Italo Mocchetti · 2015 to 2026
$29.6M
LITE CONNECT: Addressing testing gaps and epidemiologic disparities of COVID-19 amongtransgender people in the United StatesUH3AI133669 · NIAID · JOHNS HOPKINS UNIVERSITY · PI REISNER, SARI, WIRTZ, ANDREA L · 2019 to 2022
$6.9M
American Cohort to Study HIV Acquisition among Transgender Women in High Risk AreasUG3AI133669 · NIAID · JOHNS HOPKINS UNIVERSITY · PI REISNER, SARI, WIRTZ, ANDREA L · 2017 to 2018
$3.5M
PrEP Engagement Trajectories Among Transgender Women in the United StatesF31MH124582 · NIMH · JOHNS HOPKINS UNIVERSITY · PI COONEY, ERIN EILEEN · 2020 to 2022
$138k
NIAID NIH HHS P30 AI050409NIAID NIH HHS P30 AI060354NIAID NIH HHS P30 AI073961NIAID NIH HHS P30 AI094189NIAID NIH HHS P30 AI117970NIAID NIH HHS UG3 AI133669NIAID NIH HHS UH3 AI133669NIMHD NIH HHS L60 MD012898NIMH NIH HHS F31 MH124582
6 · The paper itself

Abstract

STUDY/RESEARCH

objectiveTo develop and validate a brief intimate partner violence (IPV) scale that screens for controlling behaviors and psychological abuse tactics directed toward transgender individuals. RATIONALE: Transgender individuals are at elevated risk of physical and sexual IPV compared to cisgender individuals. IPV often takes on unique dimensions against transgender individuals, such as when an abusive partner threatens to "out" the transgender person, or use other tactics that weaponize transphobia within the relationship. Standard IPV screeners do not assess this type of transgender-specific IPV (T-IPV).

methodsBetween March 2018 and October 2019, a T-IPV scale was tested in two samples (in-person and online) of transfeminine adults (i.e. assigned a male sex at birth and identify with femininity) from the eastern and southern U.S. Exploratory factor analysis (EFA) was conducted with the in-person sample (N = 661) to assess construct validity. Confirmatory factor analysis (CFA) was then used in an independent online sample (N = 481). Using the combined sample (N = 1137), convergent validity was assessed using correlations with other forms of victimization. Multivariable regression models were fit to estimate the relationship between T-IPV and health outcomes.

resultsFactor analyses yielded an 8-item unidimensional scale with moderate to good fit. Nearly half the sample (48.7%) experienced at least one scale item. Internal consistency reliability was strong (KR-20 = 0.827). Significant correlations with other forms of victimization indicated convergent validity. Lifetime T-IPV was significantly associated with psychological distress (adjusted prevalence ratio [aPR] = 1.32, 95% CI = 1.13, 1.53), PTSD (aPR = 1.50, 95%CI = 1.31, 1.72), alcohol abuse (aPR = 1.21, 95%CI = 1.01, 1.44), and drug use disorder (aPR = 1.30, 95%CI = 1.06, 2.59).

conclusionsThis T-IPV scale is a reliable and unidimensional measure with strong construct validity. T-IPV is independently associated with mental health burden and substance use. Service providers working with transgender clients should screen for T-IPV to avoid missing cases of IPV, and refer to violence response services.

Indexed as

Crime VictimsIntimate Partner ViolenceTransgender PersonsAdolescentAdultAgedFemaleHumansMaleMiddle AgedPrevalenceReproducibility of ResultsSexual BehaviorYoung AdultDomestic violenceIntimate partner violenceTransgenderTrans women

Identifiers

PMID34710821
PMCPMC8671347
OpenAlexW3207328245

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.